Upregulation of TRPC1 in microglia promotes neutrophil infiltration after ischemic stroke

Hao Qian1, Hui-Nan Zhang2, Tian Gao2

  • 1Health Management Center, Second Affiliated Hospital, Fourth Military Medical University, Xi'an 710038, China; Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an 710032, China.

Brain Research Bulletin
|February 7, 2024
PubMed

Insights

Canonical transient receptor potential 1 (TRPC1) in microglia drives neutrophil infiltration and worsens stroke injury. Reducing TRPC1 in microglia lessens brain damage and inflammation, offering a potential therapeutic target for cerebral ischemia and reperfusion injury.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Neutrophil infiltration correlates with poor outcomes in ischemic stroke.
  • Microglia-immune cell interactions in brain inflammation are not fully understood.

Purpose of the Study:

  • Investigate the role of canonical transient receptor potential 1 (TRPC1) in microglia-mediated neutrophil infiltration during cerebral ischemia and reperfusion injury (CIRI).

Main Methods:

  • Utilized male mouse models of middle cerebral artery occlusion/reperfusion (MCAO/R) and in vitro oxygen-glucose deprivation/regeneration (OGD/R).
  • Examined TRPC1 expression in microglia and employed conditional Trpc1 knockdown in microglia.
  • Assessed infarct volume, neurological deficits, neutrophil infiltration, CC-chemokine ligand (CCL) 5 and CCL2 secretion, store-operated calcium entry, and nuclear factor of activated T-cells c1 (NFATc1) levels.

Main Results:

  • TRPC1 was upregulated in microglia during MCAO/R and OGD/R.
  • Conditional Trpc1 knockdown in microglia reduced infarct size, neurological deficits, and neutrophil infiltration.
  • Trpc1 knockdown decreased CCL5 and CCL2 secretion from microglia, mitigating neutrophil infiltration.
  • TRPC1 modulated Ca2+ entry and NFATc1 activation in microglia, linking TRPC1 to CCL5/2 production.

Conclusions:

  • TRPC1 in microglia promotes neutrophil infiltration via the Ca2+/NFATc1 pathway, increasing CCL5/2 production and exacerbating CIRI.
  • Targeting TRPC1 in microglia presents a potential therapeutic strategy for reducing neurological damage in stroke.